Flourish Research is one of the largest clinical trial site networks in the United States that has expertise in a breadth of therapeutic areas and all clinical trial phases. Flourish provides patient recruitment services and clinical trial services to support the development of new medications and medical devices. Flourish has conducted over 2,000 trials to date across more than 15 therapeutic areas and over 55 indications. Since its founding, Flourish has focused on performing the highest quality trials for sponsors and CROs and providing patients with an exceptional clinical experience.
Location: United States, Texas, San Antonio
Investors 2
Date | Name | Website |
- | NMS Capita... | nms-capita... |
- | Maranon Ca... | maranoncap... |
Mentions in press and media 14
Date | Title | Description |
19.09.2024 | Flourish Research Receives Majority Investment from Genstar Capital | Flourish Research, an Apex, NC-based multi-site clinical trial organization focused on cardiovascular, metabolic, neuroscience, and infectious disease therapeutic areas, received a majority investment from Genstar Capital. The amount of the... |
14.11.2023 | NMS Capital Portfolio Company Flourish Research Announces Partnership with Merritt Island Medical Research, Further Expanding Presence in Neuroscience | New York, NY, November 14, 2023 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish”) announced today that it has partnered with Merritt Island Medical Research (“MIMR” or the “Company”). MIMR is a leading clinical research... |
15.09.2023 | NMS Capital Portfolio Company Flourish Research Announces Partnership with Valley Clinical Trials Marking the Ninth Acquisition Since the Formation of Flourish in 2021 | New York, NY, September 15, 2023 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish”) is pleased to announce the acquisition of Valley Clinical Trials (“Valley” or the “Company”). Valley is a leading clinical research site... |
29.06.2023 | Jose Alvarez Joins Flourish Research as Chief Operating Officer | Jose Alvarez, COO, Flourish Research I look forward to joining this amazing mission-driven team and sharing my experiences building and developing fast-growing organizations. - Jose Alvarez, COO, Flourish Research NEW YORK (PRWEB) June 29, ... |
01.06.2023 | Flourish Research Expands with New Acquisitions in North Carolina and Alabama | "Both partnerships will augment our existing capabilities and allow us to expand into new markets as we continue our journey to become a leader in clinical site services with a focus on diverse and underserved patient populations."... |
22.12.2022 | NMS Capital Portfolio Company Flourish Research Announces Partnership with Suncoast Research Group | New York, NY, December 16, 2022 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish”) is pleased to announce the acquisition of Suncoast Research Group, LLC (“Suncoast” or the “Company”). Suncoast is a leading, multi-therap... |
22.12.2022 | Flourish Research Announces Acquisition of Suncoast Research Group | “We welcome the Suncoast team, which has forged impressive ties with major sponsors and CROs, thanks to the success of their enrollment and quality." - Reinhold Schulz, CEO of Flourish Research NEW YORK (PRWEB) December 22, 2022 Flouri... |
18.10.2022 | Flourish Research Expands with Keystone Clinical Acquisition | We are excited to add Keystone to our expanding company, especially given Dr. Verghese’s position as a thought leader in CNS research and the deep relationships Keystone has developed with sponsor customers - Reinhold Schulz, CEO, Flourish ... |
06.10.2022 | NMS Capital Portfolio Company Flourish Research Announces Partnership with Keystone Clinical Studies | New York, NY, October 6, 2022 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish”) announced today that it has partnered with company management in the recapitalization of Keystone Clinical Studies, LLC (“Keystone”). Keyst... |
15.08.2022 | Reinhold Schulz Joins Flourish Research as Chief Executive Officer | "I’m excited for the opportunity to drive the continued growth and integration of already best-in-class sites." NEW YORK (PRWEB) August 15, 2022 Reinhold Schulz has been named Chief Executive Officer of Flourish Research, a compan... |
Show more